Cargando…
Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study
BACKGROUND: The WHO Model List of Essential Medicines for Children (EMLc) covers medicines for globally high-burden diseases. Regulatory approval in high-income countries ensures evidence and dosage form but usually focuses on diseases common in those countries and not in low- and middle-income coun...
Autores principales: | Shimazawa, Rumiko, Ikeda, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217454/ https://www.ncbi.nlm.nih.gov/pubmed/28070339 http://dx.doi.org/10.1186/s40545-016-0094-2 |
Ejemplares similares
-
Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan
por: Shimazawa, R, et al.
Publicado: (2014) -
Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?
por: Shimazawa, Rumiko, et al.
Publicado: (2013) -
Trends in licence approvals for ophthalmic medicines in the United Kingdom
por: Morgan-Warren, Peter J., et al.
Publicado: (2020) -
Landscape of Participant-Centric Initiatives for Medical Research in the United States, the United Kingdom, and Japan: Scoping Review
por: Hamakawa, Nao, et al.
Publicado: (2020) -
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
por: Shimazawa, Rumiko, et al.
Publicado: (2021)